
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…

mint Lesion's Research Suite is an advanced imaging research platform designed to support academic teams in streamlining and scaling their imaging…

At Mint Medical, we understand data as a cornerstone for improving patient care and groundbreaking research. Our mission is clear: Leave No Data…

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion…

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule…

Join our three Sales Directors, Felix Gruler, Aditya Jayaram, and Steffen Rupp, in their discussion about Mint Medical’s mission statements and how we…

“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole…

We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital…